4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0001104659-19-040970
Options or other derivatives
- Director acquired 5,714 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Ezekowitz Alan · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-07-18 | Grant or award : show line 1 in the form Stock Option (right to buy) | +5,714 | 5,714 | D |
Loading xslF345X03/a4.xml…